Academies Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Anti-PD-1 monoclonal antibody; Other: Postoperative CCRT Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Camrelizumab; Drug: Cisplatin; Drug: Carboplatin; Drug: Lobaplatin; Drug: Nedaplatin; Radiation: Radiotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials

Allergy Diagnostic Test Based on Microchip Technology
Conditions: Allergy; Allergy;Food; Allergy Pollen; Allergy Drug Interventions: Diagnostic Test: Routine allergy tests; Diagnostic Test: Newly developed microarray-based diagnostic test system Sponsors: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

Camrelizumab Combined With Apatinib 、Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma (Siewert II-III) Interventions: Drug: Camrelizumab+Apatinib+Oxaliplatin+Paclitaxel (Albumin Bound) +radiotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials

High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB
Conditions: Nosocomial Pneumonia Interventions: Drug: Sham treatment; Drug: 200- ppm NO Sponsors: Tomsk National Research Medical Center of the Russian Academy of Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Telecommunication Technology-based Online Survey
Conditions: Risk Factors; Polypharmacy; Drug Drug Interaction; Self Medication Interventions: Other: Online Survey Sponsors: Tomsk National Research Medical Center of the Russian Academy of Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials

AZA Combined With RCHOP in P53-mutated DLBCL.
Conditions: DLBCL - Diffuse Large B Cell Lymphoma; TP53 Interventions: Drug: Azacitidine in combination with R-CHOP Sponsors: The First Affiliated Hospital of Xiamen University; Jiangsu Provincial People ' s Hospital; Sun Yat-sen University; Chinese Academy of Medical Sciences; Shanxi Province Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials

Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Mitoxantrone hydrochloride liposome; Drug: Capecitabine; Drug: Mitoxantrone hydrochloride liposome; Drug: Capecitabine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; CSPC Ouyi Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

Cadonilimab + FOLFOX Versus FOLFOX in the Neoadjuvant Treatment of pMMR/MSS Locally Advanced Colorectal Cancer
Conditions: Locally Advanced Colorectal Carcinoma Interventions: Drug: Cadonilimab; Drug: FOLFOX regimen Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials

Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
Conditions: Colorectal Surgery; Benign or Malignant Rectal or Colon Tumors Sponsors: Bordeaux Colorectal Institute Academy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials

LCI in Chronic Atrophic Gastritis and Early Gastric Cancer
Conditions: CAG - Chronic Atrophic Gastritis; EGC - Early Gastric Cancer Interventions: Other: Compare color information and mucosal microvascular density Sponsors: Affiliated Hospital to Academy of Military Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

Single Arm Clinical Study on the Safety and Efficacy of Personalized KSX01-TCRT in Patients With Advanced Solid Tumors
Conditions: Refractory Solid Tumors; Relapsed Solid Tumors Interventions: Biological: KSX01-TCRT cell therapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
Conditions: Thrombosis, Venous; Cancer; Catheter Complications Interventions: Drug: Edoxaban Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care
Conditions: Health Services Accessibility; First-line Treatment; Osteoarthritis Interventions: Behavioral: Digitally delivered first-line treatment for osteoarthritis; Behavioral: Face-to-face first-line treatment for osteoarthritis Sponsors: Joint Academy; Lund University; The Swedish Osteoarthritis Registry Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
Conditions: Rectal Cancer Interventions: Procedure: Dissection of the No.253 lymph node; Procedure: Omitting the dissection of the No.253 lymph node Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking Union Medical College Hospital; China-Japan Friendship Hospital; Chinese PLA General Hospital; Ruijin Hospital; Fudan University; West China Hospital; Peking University Cancer Hospital& Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials